SCGB1A1 and inflammatory response: Previous reports demonstrated that the levels of pro-inflammatory cytokines, IL-4, IL-5, and IL-13, and airway inflammation were suppressed in mice pre-treated with SCGB1A1 or SCGB3A2 in the OVA-induced allergic airway inflammation model [15,24].